Clinical Trial Update: Lipoprotein-associated Phospholipase A2 (Lp-PLA2) Progenitor Cells and Coronary Atherosclerosis in Humans [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating lipoprotein-associated phospholipase A2 progenitor cells in coronary atherosclerosis has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Atherosclerosis
• Endothelial Dysfunction

Snippet

Sponsor: Mayo Clinic | Conditions: Endothelial Dysfunction | Phase 3 | Status: COMPLETED | Results posted: 2017-03-15